Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial.

Philip S Helliwell Phillip J MeaseArthur KavanaughLaura C Coates Philip S HelliwellAtul DeodharVibeke StrandGregory KricorianLyrica X H LiuDavid CollierDafna D Gladman

Published in: RMD open (2022)

Results from our analysis suggest that presence of dactylitis and nail disease, but not enthesitis, are associated with improved outcomes in patients with early PsA who were treated with methotrexate and/or etanercept.

Keyphrases

prostate cancer
rheumatoid arthritis
juvenile idiopathic arthritis
radical prostatectomy
clinical trial
study protocol
high dose
randomized controlled trial
ankylosing spondylitis
type diabetes
rheumatoid arthritis patients
phase ii
adipose tissue
metabolic syndrome
combination therapy